ACRUX Ltd Cash Flow Conversion Efficiency
ACRUX Ltd cash flow conversion efficiency. Based on the latest financial reports, ACRUX Ltd (ACR) has a cash flow conversion efficiency ratio of -3.930x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.02 Million ≈ $-2.84 Million USD) by net assets (AU$1.02 Million ≈ $723.84K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ACRUX Ltd (2002–2025)
Cash flow conversion efficiency of ACRUX Ltd from 2002 to 2025. This chart illustrates how ACRUX Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACRUX Ltd (ACR) share price today for real-time trading data and today's change.
ACRUX Ltd Cash Flow Conversion Ratio Explained
ACRUX Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ACRUX Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ACRUX Ltd ranked by their cash flow conversion efficiency. Also see market value of ACRUX Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Schroder Income Growth Fund
LSE:SCF
|
0.006x |
|
Ecofin Global Utilities and Infrastructure Trust plc
LSE:EGL
|
0.000x |
|
Imprimerie Chirat Société Anonyme
PA:MLIMP
|
N/A |
|
Moho Resources Ltd
AU:MOH
|
-0.204x |
|
Desert Control AS
OL:DSRT
|
-0.415x |
|
LOBE SCIENCES LTD
F:6YX0
|
N/A |
|
Mlabs Systems Bhd
KLSE:0085
|
0.091x |
|
TAIZHOU WATER GRP. H YC 1
F:GX5
|
N/A |
Annual Cash Flow Conversion Efficiency for ACRUX Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of ACRUX Ltd from 2002 to 2025. Review free cash flow generation of ACRUX Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$1.02 Million ≈ $723.84K |
AU$-5.47 Million ≈ $-3.87 Million |
-5.348x | -307.16% |
| 2024-06-30 | AU$3.28 Million ≈ $2.32 Million |
AU$-4.30 Million ≈ $-3.04 Million |
-1.313x | -1724.77% |
| 2023-06-30 | AU$8.70 Million ≈ $6.15 Million |
AU$703.00K ≈ $497.42K |
0.081x | +108.33% |
| 2022-06-30 | AU$9.09 Million ≈ $6.43 Million |
AU$-8.82 Million ≈ $-6.24 Million |
-0.970x | -57.00% |
| 2021-06-30 | AU$18.47 Million ≈ $13.07 Million |
AU$-11.41 Million ≈ $-8.08 Million |
-0.618x | +6.95% |
| 2020-06-30 | AU$12.85 Million ≈ $9.09 Million |
AU$-8.53 Million ≈ $-6.04 Million |
-0.664x | -46.59% |
| 2019-06-30 | AU$21.94 Million ≈ $15.52 Million |
AU$-9.94 Million ≈ $-7.03 Million |
-0.453x | -157.07% |
| 2018-06-30 | AU$29.97 Million ≈ $21.21 Million |
AU$-5.28 Million ≈ $-3.74 Million |
-0.176x | -244.00% |
| 2017-06-30 | AU$43.92 Million ≈ $31.08 Million |
AU$5.38 Million ≈ $3.80 Million |
0.122x | -67.46% |
| 2016-06-30 | AU$43.89 Million ≈ $31.05 Million |
AU$16.51 Million ≈ $11.68 Million |
0.376x | +45.25% |
| 2015-06-30 | AU$40.62 Million ≈ $28.74 Million |
AU$10.52 Million ≈ $7.44 Million |
0.259x | -70.06% |
| 2014-06-30 | AU$42.06 Million ≈ $29.76 Million |
AU$36.37 Million ≈ $25.73 Million |
0.865x | +538.23% |
| 2013-06-30 | AU$46.75 Million ≈ $33.08 Million |
AU$6.33 Million ≈ $4.48 Million |
0.135x | +395.86% |
| 2012-06-30 | AU$53.10 Million ≈ $37.57 Million |
AU$-2.43 Million ≈ $-1.72 Million |
-0.046x | -103.22% |
| 2011-06-30 | AU$45.71 Million ≈ $32.34 Million |
AU$65.10 Million ≈ $46.07 Million |
1.424x | +138.17% |
| 2010-06-30 | AU$80.47 Million ≈ $56.94 Million |
AU$48.12 Million ≈ $34.05 Million |
0.598x | +422.97% |
| 2009-06-30 | AU$31.22 Million ≈ $22.09 Million |
AU$-5.78 Million ≈ $-4.09 Million |
-0.185x | -160.08% |
| 2008-06-30 | AU$38.11 Million ≈ $26.96 Million |
AU$-2.71 Million ≈ $-1.92 Million |
-0.071x | +83.13% |
| 2007-06-30 | AU$18.25 Million ≈ $12.91 Million |
AU$-7.70 Million ≈ $-5.45 Million |
-0.422x | -5.57% |
| 2006-06-30 | AU$20.58 Million ≈ $14.56 Million |
AU$-8.23 Million ≈ $-5.82 Million |
-0.400x | -99.63% |
| 2005-06-30 | AU$29.48 Million ≈ $20.86 Million |
AU$-5.90 Million ≈ $-4.18 Million |
-0.200x | +57.55% |
| 2004-06-30 | AU$8.41 Million ≈ $5.95 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-0.472x | -200.45% |
| 2002-06-30 | AU$17.49 Million ≈ $12.37 Million |
AU$-2.74 Million ≈ $-1.94 Million |
-0.157x | -- |
About ACRUX Ltd
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more